Advertisement
Advanced Search
< Previous Article
Next Article >
March 2009Volume 27, Issue 3, Pages 370.e1–370.e3
Switch to Standard ViewSwitch to Enhanced View

Sunitinib-induced myxedema coma

Shey-Ying Chen
x
Shey-Ying Chen
, MD
Department of Emergency Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 100, Taiwan
Pei-Chieh Kao
x
Pei-Chieh Kao
, MD
Department of Emergency Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 100, Taiwan
Zhong-Zhe Lin
x
Zhong-Zhe Lin
, MD
Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 100, Taiwan
Wen-Chu Chiang
x
Wen-Chu Chiang
, MD
Department of Emergency Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 100, Taiwan
Cheng-Chung Fang
x
Cheng-Chung Fang
Search for articles by this author

Correspondence

  • Tel.: +886 2 23123456x2831; fax: +886 2 23223150.
, MDcorrespondence
x
Cheng-Chung Fang
Search for articles by this author

Correspondence

  • Tel.: +886 2 23123456x2831; fax: +886 2 23223150.
Department of Emergency Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 100, Taiwan
DOI: http://dx.doi.org/10.1016/j.ajem.2008.07.012

References

  1. [1]Desai, J., Yassa, L., Marqusee, E. et al, Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med. 2006;145:660–664.
  2. [2]Rini, B.I., Tamaskar, I., Shaheen, P. et al, Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2007;99:81–83.
  3. [3]Porta, C., Paglino, C., Imarisio, I. et al, Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib. Clin Exp Med. 2007;7:127–134.
  4. [4]Feldman, D.R., Martorella, A.J., Robbins, R.J. et al, Re: hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2007;99:974–975.
  5. [5]Faris, J.E., Moore, A.F., Daniels, G.H. Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report. Thyroid. 2007;17:1147–1149.
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
Access this article on
ScienceDirect
Visit ScienceDirect to see if you have access via your institution.

Article Tools

Related Articles

Searching for related articles..

Advertisement
< Previous Article
Next Article >
March 2009Volume 27, Issue 3, Pages 370.e1–370.e3